• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Treating Complicated Grief: Grief-Focused Psychotherapy Is More Effective Than Citalopram

Treating Complicated Grief: Grief-Focused Psychotherapy Is More Effective Than Citalopram

September 1, 2016
Bret A. Moore, Psy.D, ABPP
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
bret-a-moore-psyd-abppBret A. Moore, Psy.D, ABPP Board-Certified Clinical Psychologist, San Antonio, TX Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Shear M et al, JAMA Psychiatry, 2016;73:685–694; Study type: Randomized placebo-controlled trial

Complicated grief (CG) is a relatively common response in those who have suffered the loss of a loved one. In DSM-5, it is listed in the section on conditions for further study, and it is called “persistent complex bereavement disorder.” To meet the diagnostic criteria, your patient must have suffered bereavement for at least 6 months, and must have had at least 3 of a list of symptoms for 1 month. While there is some overlap with major depression, CG has core symptoms of yearning and sorrow and great difficulty accepting the reality of death. It’s one of the more controversial proposed DSM disorders, with critics seeing it as medicalizing a normal human experience. Nonetheless, there has been a lot of research on how to help people with CG, and a specific psychotherapy, called complicated grief treatment (CGT), is clearly effective. But how does therapy compare with a standard antidepressant?

To answer this question, researchers recruited 395 individuals diagnosed with CG; the majority were women, the mean age was 53, and the mean number of years since the loss was 4.7. These patients were randomized to one of four groups: citalopram (n = 101), placebo (n = 99), CGT with citalopram (n = 99), and CGT with placebo (n = 96). The citalopram (CIT) was flexibly dosed with an average of 33.9 mg/day. Spanning 20 weeks, patients were assessed monthly with the Clinical Global Impression scale (CGI), which was the primary outcome measure. Secondary measures to assess depression included the self-report version of the Quick Inventory of Depressive Symptoms and a modified version of the Columbia Suicide Scale.

Results
The main outcome measure was the response rate after 20 weeks, defined as “much improved” or “very much improved” on the Clinical Global Impression scale. Patients in the CGT groups did the best, whether the therapy was combined with CIT (83.7% response rate) or with placebo (82.5%). Adding CGT to CIT was more effective than CIT alone (83.7% vs. 69.3%), and CIT alone was numerically superior to placebo, but it didn’t quite reach statistical significance (69.3% vs. 54.8%, p = 0.11). On a secondary measure of depressive symptoms, adding CIT to CGT did outperform CGT alone.

TCPR’s Take
CGT was clearly more effective for complicated grief than CIT. While CIT alone did not statistically outperform placebo, there is a factor that might have put the medication at a disadvantage. The 2011 FDA warning about high CIT doses causing EKG abnormalities was issued a year into the study, forcing researchers to decrease the maximum dose allowed from 60 mg to 40 mg. That led to a lower-than-planned CIT average dosing of 33.9 mg, which may have limited its efficacy.

Practice implications
The bottom line is that while CGT is the treatment of choice for CG, adding an SSRI to this psychotherapy might provide a small efficacy boost for depressive symptoms.
General Psychiatry
KEYWORDS depressive_disorder dsm psychopharmacology_tips research-update
Bret a moore psyd abpp
Bret A. Moore, Psy.D, ABPP

More from this author
www.thecarlatreport.com
Issue Date: September 1, 2016
SUBSCRIBE NOW
Table Of Contents
Treating Complicated Grief: Grief-Focused Psychotherapy Is More Effective Than Citalopram
Take The CME Post-Test for Pain Management, TCPR, September 2016
Managing Pain: A Cognitive Behavioral Therapist’s Approach
Evaluating and Treating Pain in Psychiatric Patients
Tales from the History of Psychiatry: Opium, an Ancient Psychotropic
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.